The 2024 mRNA Technology Conference will be held 21-24 April 2024 in Boston, Massachusetts. The event will showcase never before presented research and technology advances from both established leaders and early career professionals providing insights into present, developing, and future mRNA Applications. Highlighted program sessions include: Manufacturing: IVT Process Optimization and Reactors Design Analytical Characterization

SPIE's Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensing XXV Conference will be held 22-25 April 2024 in National Harbor, Maryland. This conference provides an unprecedented forum for authors from government, industry, and academia to address a wide variety of CBRNE sensing issues, technologies, and advances in algorithms and signal process of threat related scenarios.

On behalf of the US Defense Threat Reduction Agency (DTRA), Sandia National Laboratories will host "Developing Laboratory Best Practices for Rapid Inactivation of High Consequences Pathogens and Sensitive Equipment Workshop” in April 2024. Stakeholders from Central Veterinary Laboratories (CVL) and Central Public Health Laboratories (CPHL) from the Government of Iraq (GOI) and Iraqi Kurdistan Region (IKR)

On behalf of the US Defense Threat Reduction Agency (DTRA), Sandia National Laboratories will host a series of virtual and in-person training workshops in Antananarivo, Madagascar to support ongoing efforts to build participants’ ability to train others and create a global biorisk management trainers’ network across East Africa. By the end of the four workshops,

The World Orphan Drug Congress will be held 23-25 April 2024 in Boston, Massachusetts. The event brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving